TGFBI and nasopharyngeal carcinoma: Our findings demonstrate that miR-449b directly binds and represses TGFBI mRNA, altering the TGFBI-TGFβ1 balance to facilitate activation of the TGFβ pathway, thereby inducing treatment resistance in NPC.